Articles

Trump’s return should favor growth stocks. Here are 10 with the most upside.

Quantitative strategists at Jefferies expect Donald Trump’s return as president to enable a continued run for growth stocks; they suggest avoiding value as an investment style.

Struggling pot company Canopy Growth taps turnaround pro from outside the industry as CEO

With its stock price down about 19% so far this year and a string of money-losing quarters, Canopy Growth tapped Luc Mongeau as chief executive, taking over from David Klein on Jan. 6.

Kohl’s stock sinks after another sales miss, as shoes and clothes remain weak

Kohl’s stock tanks after yet another sales miss, as the retailer’s core apparel and shoes businesses remain weak.

Inflation is heading in the wrong direction. Just how bad is it?

The rate of inflation is going to get worse before it gets better, raising questions about how fast the Federal Reserve can cut interest rates.

Burlington’s stock falls as warm weather hurts its coat sales

“Our third quarter comp trend started out very strongly, but then warmer temperatures from mid-September onwards slowed our sales momentum,” the company’s CEO said.

Abercrombie & Fitch’s profit beats analyst estimate but stock falls

Abercrombie & Fitch Co.’s stock fell 1.6% in premarket trading on Tuesday despite its better-than-expected third-quarter revenue and profit.

Americans may think twice when Musk and Ramaswamy try to break the things they value

Trump’s DOGE leaders look for inspiration from Javier Milei, Argentina’s chainsaw-wielding president.

J.M. Smucker Co.’s sales rise 17% with boost from Hostess acquisition

Food giant cites “strong” second quarter performance of brands such as Uncrustables, Meow Mix, Café Bustelo and Jif.

Why GM, Ford stocks are falling after Trump’s tariff plan for Mexico and Canada

Stocks of GM and Ford took a hit, amid concerns that Trump’s plan for tariffs on imports from Mexico and Canada could cut auto sales more than a million cars.

Best Buy’s stock slides as ‘softer-than-expected’ demand leads to sales, earnings miss

Macro uncertainty, customers waiting for deals and sales events, and distraction during the run-up to the election led to softer-than-expected demand, according to Best Buy CEO Corie Barry.

Amgen’s stock slides 7.8% after weight-loss drug data lags analyst expectations

Amgen’s MariTide achieves up to 20% weight loss in mid-stage trial, but analysts were expecting up to 25%.

Dick’s Sporting Goods’ stock soars 6% as earnings boosted by strong back-to-school season

The retailer beat estimates for the third quarter and raised its guidance.
1 768 769 770 771 772 2,500